These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 21497957)

  • 1. Anticancer effects of the metabolic products of the resveratrol analogue, DMU-212: structural requirements for potency.
    Androutsopoulos VP; Ruparelia KC; Papakyriakou A; Filippakis H; Tsatsakis AM; Spandidos DA
    Eur J Med Chem; 2011 Jun; 46(6):2586-95. PubMed ID: 21497957
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synthesis and Evaluation of 2-Naphthaleno trans-Stilbenes and Cyanostilbenes as Anticancer Agents.
    Madadi NR; Penthala NR; Ketkar A; Eoff RL; Trujullo-Alonso V; Guzman ML; Crooks PA
    Anticancer Agents Med Chem; 2018; 18(4):556-564. PubMed ID: 28403783
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Resveratrol analog trans 3,4,5,4'-tetramethoxystilbene (DMU-212) mediates anti-tumor effects via mechanism different from that of resveratrol.
    Ma Z; Molavi O; Haddadi A; Lai R; Gossage RA; Lavasanifar A
    Cancer Chemother Pharmacol; 2008 Dec; 63(1):27-35. PubMed ID: 18286288
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lead identification of conformationally restricted β-lactam type combretastatin analogues: synthesis, antiproliferative activity and tubulin targeting effects.
    Carr M; Greene LM; Knox AJ; Lloyd DG; Zisterer DM; Meegan MJ
    Eur J Med Chem; 2010 Dec; 45(12):5752-66. PubMed ID: 20933304
    [TBL] [Abstract][Full Text] [Related]  

  • 5. 3'-hydroxy-3,4,5,4'-tetramethoxystilbene, the metabolite of resveratrol analogue DMU-212, inhibits ovarian cancer cell growth in vitro and in a mice xenograft model.
    Piotrowska-Kempisty H; Ruciński M; Borys S; Kucińska M; Kaczmarek M; Zawierucha P; Wierzchowski M; Łażewski D; Murias M; Jodynis-Liebert J
    Sci Rep; 2016 Sep; 6():32627. PubMed ID: 27585955
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Structural modification of resveratrol leads to increased anti-tumor activity, but causes profound changes in the mode of action.
    Scherzberg MC; Kiehl A; Zivkovic A; Stark H; Stein J; Fürst R; Steinhilber D; Ulrich-Rückert S
    Toxicol Appl Pharmacol; 2015 Aug; 287(1):67-76. PubMed ID: 26044878
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Design, synthesis and antiproliferative activity of the new conjugates of E7010 and resveratrol as tubulin polymerization inhibitors.
    Kamal A; Ashraf M; Basha ST; Ali Hussaini SM; Singh S; Vishnuvardhan MV; Kiran B; Sridhar B
    Org Biomol Chem; 2016 Jan; 14(4):1382-94. PubMed ID: 26676480
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Design, synthesis, in vitro antiproliferative activity and apoptosis-inducing studies of 1-(3',4',5'-trimethoxyphenyl)-3-(2'-alkoxycarbonylindolyl)-2-propen-1-one derivatives obtained by a molecular hybridisation approach.
    Preti D; Romagnoli R; Rondanin R; Cacciari B; Hamel E; Balzarini J; Liekens S; Schols D; Estévez-Sarmiento F; Quintana J; Estévez F
    J Enzyme Inhib Med Chem; 2018 Dec; 33(1):1225-1238. PubMed ID: 30141353
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Flavokawain derivative FLS induced G2/M arrest and apoptosis on breast cancer MCF-7 cell line.
    Ali NM; Akhtar MN; Ky H; Lim KL; Abu N; Zareen S; Ho WY; Alan-Ong HK; Tan SW; Alitheen NB; Ismail JB; Yeap SK; Kamarul T
    Drug Des Devel Ther; 2016; 10():1897-907. PubMed ID: 27358555
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Resveratrol analogue 3,4,4',5-tetramethoxystilbene inhibits growth, arrests cell cycle and induces apoptosis in ovarian SKOV-3 and A-2780 cancer cells.
    Piotrowska H; Myszkowski K; Ziółkowska A; Kulcenty K; Wierzchowski M; Kaczmarek M; Murias M; Kwiatkowska-Borowczyk E; Jodynis-Liebert J
    Toxicol Appl Pharmacol; 2012 Aug; 263(1):53-60. PubMed ID: 22687606
    [TBL] [Abstract][Full Text] [Related]  

  • 11. From a multipotent stilbene to soluble epoxide hydrolase inhibitors with antiproliferative properties.
    Buscató E; Büttner D; Brüggerhoff A; Klingler FM; Weber J; Scholz B; Zivković A; Marschalek R; Stark H; Steinhilber D; Bode HB; Proschak E
    ChemMedChem; 2013 Jun; 8(6):919-23. PubMed ID: 23596124
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Design, synthesis, and biological evaluation of novel combretastatin A-4 thio derivatives as microtubule targeting agents.
    Stefański T; Mikstacka R; Kurczab R; Dutkiewicz Z; Kucińska M; Murias M; Zielińska-Przyjemska M; Cichocki M; Teubert A; Kaczmarek M; Hogendorf A; Sobiak S
    Eur J Med Chem; 2018 Jan; 144():797-816. PubMed ID: 29291446
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A novel all-trans retinoic acid derivative 4-amino‑2‑trifluoromethyl-phenyl retinate inhibits the proliferation of human hepatocellular carcinoma HepG2 cells by inducing G0/G1 cell cycle arrest and apoptosis via upregulation of p53 and ASPP1 and downregulation of iASPP.
    Liu H; Chen F; Zhang L; Zhou Q; Gui S; Wang Y
    Oncol Rep; 2016 Jul; 36(1):333-41. PubMed ID: 27177208
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Regulation of p53 and cell proliferation by resveratrol and its derivatives in breast cancer cells: an in silico and biochemical approach targeting integrin αvβ3.
    Hsieh TC; Wong C; John Bennett D; Wu JM
    Int J Cancer; 2011 Dec; 129(11):2732-43. PubMed ID: 21225623
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Design, synthesis and in vitro antitumor activity of novel N-substituted-4-phenyl/benzylphthalazin-1-ones.
    Eldehna WM; Ibrahim HS; Abdel-Aziz HA; Farrag NN; Youssef MM
    Eur J Med Chem; 2015 Jan; 89():549-60. PubMed ID: 25462265
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Design, synthesis and antibreast cancer MCF-7 cells biological evaluation of heterocyclic analogs of resveratrol.
    Du C; Dong MH; Ren YJ; Jin L; Xu C
    J Asian Nat Prod Res; 2017 Sep; 19(9):890-902. PubMed ID: 27809606
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antiproliferative activity of stilbene derivatives and other constituents from the stem bark of
    Abdel Bar FM; Abbas GM; Gohar AA; Lahloub MI
    Nat Prod Res; 2020 Dec; 34(24):3506-3513. PubMed ID: 30822142
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Design, synthesis of phenstatin/isocombretastatin-oxindole conjugates as antimitotic agents.
    Kumar GB; Nayak VL; Sayeed IB; Reddy VS; Shaik AB; Mahesh R; Baig MF; Shareef MA; Ravikumar A; Kamal A
    Bioorg Med Chem; 2016 Apr; 24(8):1729-40. PubMed ID: 26970659
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Anti-tumor properties of methoxylated analogues of resveratrol in malignant MCF-7 but not in non-tumorigenic MCF-10A mammary epithelial cell lines.
    van den Brand AD; Villevoye J; Nijmeijer SM; van den Berg M; van Duursen MBM
    Toxicology; 2019 Jun; 422():35-43. PubMed ID: 31004704
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Anticancer effect of (E)-2-hydroxy-3',4,5'-trimethoxystilbene on breast cancer cells by mitochondrial depolarization.
    Chae YS; Kim JG; Jung HJ; Yang JD; Jung JH; Aiyar SE; Kim S; Park H
    Cancer Chemother Pharmacol; 2011 Aug; 68(2):349-58. PubMed ID: 20978764
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.